(EMN) Eastman Chemical - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2774321002
EMN: Chemicals, Polymers, Plastics, Fibers, Additives, Solvents
Eastman Chemical Company (NYSE: EMN) stands as a prominent player in the specialty materials sector, operating across the United States, China, and international markets. With a rich history dating back to 1920, the company has established itself as a leader in providing innovative chemical solutions. Its diverse portfolio caters to a wide array of industries, making it a pivotal contributor to various aspects of modern life.
The companys Additives & Functional Products segment is a cornerstone, offering essential chemicals used in everyday products. From paints and coatings to food safety solutions, these additives are integral to enhancing product performance and durability. This segments contributions are felt across transportation, personal care, and agriculture, underscoring their importance in both industrial and consumer applications.
In the realm of Advanced Materials, Eastman excels in producing specialized polymers and biopolymers. These materials are crucial in the manufacturing of electronics and medical devices, fields that are experiencing rapid growth. The use of biopolymers, in particular, aligns with the increasing demand for sustainable and eco-friendly products, positioning Eastman as a forward-thinking supplier in this space.
The Chemical Intermediates segment provides the foundational chemicals necessary for various industrial processes. This includes the production of solvents and plasticizers, which are vital for construction and health industries. Notably, Eastmans shift towards non-phthalate plasticizers responds to regulatory changes and consumer preferences, ensuring safer and more compliant products.
The Fibers segment rounds out Eastmans offerings with materials used in filtration, textiles, and specialty papers. While known for their role in cigarette filters, these fibers also find applications in industrial and
Additional Sources for EMN Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
EMN Stock Overview
Market Cap in USD | 9,046m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Diversified Chemicals |
IPO / Inception | 1993-10-10 |
EMN Stock Ratings
Growth Rating | 20.3 |
Fundamental | 36.4 |
Dividend Rating | 70.0 |
Rel. Strength | -10.6 |
Analysts | 3.74/5 |
Fair Price Momentum | 74.39 USD |
Fair Price DCF | 130.97 USD |
EMN Dividends
Dividend Yield 12m | 3.78% |
Yield on Cost 5y | 7.21% |
Annual Growth 5y | 4.07% |
Payout Consistency | 98.3% |
EMN Growth Ratios
Growth Correlation 3m | -76.1% |
Growth Correlation 12m | -21.3% |
Growth Correlation 5y | 16.6% |
CAGR 5y | 11.00% |
CAGR/Max DD 5y | 0.25 |
Sharpe Ratio 12m | -0.37 |
Alpha | -24.06 |
Beta | 1.007 |
Volatility | 46.13% |
Current Volume | 0k |
Average Volume 20d | 1391.6k |
As of April 19, 2025, the stock is trading at USD 76.76 with a total of 0 shares traded.
Over the past week, the price has changed by -2.03%, over one month by -15.90%, over three months by -17.92% and over the past year by -17.32%.
Partly, yes. Based on ValueRay Fundamental Analyses, Eastman Chemical (NYSE:EMN) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.35 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EMN as of April 2025 is 74.39. This means that EMN is currently overvalued and has a potential downside of -3.09%.
Eastman Chemical has received a consensus analysts rating of 3.74. Therefor, it is recommend to hold EMN.
- Strong Buy: 6
- Buy: 2
- Hold: 11
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, EMN Eastman Chemical will be worth about 80.7 in April 2026. The stock is currently trading at 76.76. This means that the stock has a potential upside of +5.17%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 110.9 | 44.5% |
Analysts Target Price | 115.1 | 50% |
ValueRay Target Price | 80.7 | 5.2% |